TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis

@article{Li2017TAK1IA,
  title={TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis},
  author={Jie Li and Chao Liang and Zongkang Zhang and Xiao-hua Pan and Songlin Peng and W. W. Lee and Aiping Lu and Zhixiu Lin and Ge Zhang and Wing Nang Leung and Baoting Zhang},
  journal={Cell Discovery},
  year={2017},
  volume={3}
}
Pneumoconiosis, caused by inhalation of mineral dusts, is a major occupational disease worldwide. Currently, there are no effective drugs owing to a lack of potential therapeutic targets during either the inflammation or fibrosis molecular events in pneumoconiosis. Here, we performed microarrays to identify aberrantly expressed genes in the above molecular events in vitro and found a hub gene transforming growth factor-β-activated kinase 1 (TAK1), which was highly expressed and activated in… 
Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity.
TLDR
Resveratrol may have a potential therapeutic effect on gouty arthritis by inhibiting TAK1 activity, which is closely associated with the NF-κB and MAPK signaling pathways.
The role of natural products in the prevention and treatment of pulmonary fibrosis: a review.
TLDR
These natural products target oxidative stress, inflammatory injury, epithelial-mesenchymal transition (EMT), fibroblast activation, extracellular matrix accumulation and metabolic regulation, and the mechanisms involve the NF-κB, TGF-β1/Smad, PI3K/Akt, p38 MAPK, Nrf2-Nox4, and AMPK signaling pathways.
Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals
TLDR
Natural products, including plant extracts and active compound that directly target the processes involved in PF, could be suitable therapeutic options with less adverse effects.
Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis
TLDR
It is reported that the stepwise elevation of intrinsic p38 signaling in the lungs is correlated with a worsening severity of bleomycin-induced fibrosis, indicating an importance of this pathway in the progression of pulmonary fibrosis.
TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
TLDR
The rationales of therapeutic strategies based on TAK1 inhibition for the treatment of pathological angiogenesis are highlighted and the crosstalk between Tak1 and signaling pathways involved in pathological ang iogenesis is discussed.
Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling
TLDR
Lgals3bp plays a critical role in the suppression of colitis and colon tumorigenesis through the downregulation of the TAK1-NF-κB-cytokine axis, suggesting that LGALS3BP is a novel immunotherapeutic target for colon inflammation and tumorsigenesis.
CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts.
TLDR
The findings indicate that CPEB1 and C PEB4 are involved in the regulation of the TAK1 and Smad signalings in human macrophages and dermal fibroblasts and may play a role in cutaneous scarring responses.
Myeloid Differentiation Factor 2 in the Heart: Bench to bedside evidence for potential clinical benefits?
TLDR
The reports from in vitro, in vivo, and clinical studies regarding the role of MD2 and the effects ofMD2 inhibitors on cardiac inflammation, dysfunction, fibrosis, and remodeling are summarized to encourage future clinical use as a novel anti-inflammatory agent.
TAK1 blockade as a therapy for retinal neovascularization
TLDR
Results reveal that inhibition of TAK1 signaling may have therapeutic value for the treatment of pathological angiogenesis in the retina.
Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases
TLDR
In this review, the recent progress in the studies of lung-protective effects and underlying mechanisms of resveratrol are highlighted and traditional Chinese prescriptions containing resver atrol as promising therapeutic options were summarized for the treatment of lung and respiratory diseases.
...
1
2
3
4
...

References

SHOWING 1-10 OF 85 REFERENCES
Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs
TLDR
DQ12 quartz exposure induced acute and chronic functional activation of the inflammasome in the heterogeneous cell populations of the lung in associated with its crystalline surface reactivity, indicating that the development of silicosis and inflammaome activation is determined by crystalline silica surface reactsivity.
New developments in the understanding of immunology in silicosis
  • F. Huaux
  • Medicine
    Current opinion in allergy and clinical immunology
  • 2007
TLDR
New pathogenic routes involving innate receptors and antiinflammation as well as new antifibrotic immune mediators have been recently described in experimental silicosis, highlighting new potential therapeutic targets and strategies.
TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
TLDR
The results indicate that TAK1 inhibition with OZ was associated with a lower frequency of autoimmune diabetes in NOD mice, and the net effect of Tak1 inhibition in Nod mice appears to be protective rather than disease-enhancing.
TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells*
TLDR
It is shown that transforming growth factor β-activated kinase 1 (TAK1) is an essential intermediate of NOD2 signaling and its ablation may impair the skin barrier function leading to inflammation.
Silicosis: a review.
TLDR
Due to the association between occupational exposure to silica and the ubsequent development of silicosis, a variety of federal and state agencies have initiated strict regulations aimed at preventing the development of ilicosis in certain workers.
Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.
TLDR
An intratracheally instilled lentiviral system able to deliver genes selectively to as many as 70% of alveolar macrophages (AMs) in the mouse lung is described and it is suggested that these differentiated cells may be a possible target cell population for in vivo gene therapy applications, including the sustained correction of hAAT deficiency.
Silicosis and coal workers' pneumoconiosis.
Exposure to coal mine dust and/or crystalline silica results in pneumoconiosis with initiation and progression of pulmonary fibrosis. This review presents characteristics of simple and complicated
The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
TLDR
This review will focus on discussing novel data and highlighting growing interest in deepening the understanding of the profibrotic role of TGF-β and its direct or indirect targeting for disease modulation.
Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF‐β/Smad3 Pathway
TLDR
The results identify Sirt1 as an important protective factor for renal fibrosis in a CKD rodent model, and the protective function of Sirt 1 is attributable to its action on TGF‐β/Smad3 signaling.
Mechanistically Identified Suitable Biomarkers of Exposure, Effect, and Susceptibility for Silicosis and Coal-Worker'S Pneumoconiosis: A Comprehensive Review
  • M. Gulumian, P. Borm, +4 authors J. Murray
  • Chemistry, Medicine
    Journal of toxicology and environmental health. Part B, Critical reviews
  • 2006
TLDR
A number of “ideal” biological markers of effect were identified, namely, Clara cell protein-16 (CC16) (serum), tumor necrosis factor-α (TNF-α) (Monocyte release), interleukin-8 (IL-8) (monocyte release) and reactive oxygen species (ROS) measurement by chemiluminescence (neutrophil release).
...
1
2
3
4
5
...